EU Empagliflozin Indication to Be Expanded for CVD Prevention? EU Empagliflozin Indication to Be Expanded for CVD Prevention?

The European Medicines Agency has recommended that the indication for empagliflozin be widened from emphasizing glycemic control to encompassing CVD in type 2 diabetes patients.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news